nimodipine has been researched along with Obesity in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Debette, S | 1 |
| Wolf, C | 1 |
| Lambert, JC | 1 |
| Crivello, F | 1 |
| Soumaré, A | 1 |
| Zhu, YC | 1 |
| Schilling, S | 1 |
| Dufouil, C | 1 |
| Mazoyer, B | 1 |
| Amouyel, P | 1 |
| Tzourio, C | 1 |
| Elbaz, A | 1 |
1 other study available for nimodipine and Obesity
| Article | Year |
|---|---|
Abdominal obesity and lower gray matter volume: a Mendelian randomization study.
Topics: Aged; Aging; Anthropometry; Body Mass Index; Brain; Cerebral Infarction; Cohort Studies; Female; Hip | 2014 |